236 related articles for article (PubMed ID: 29269518)
1. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.
Bressy C; Lac S; Nigri J; Leca J; Roques J; Lavaut MN; Secq V; Guillaumond F; Bui TT; Pietrasz D; Granjeaud S; Bachet JB; Ouaissi M; Iovanna J; Vasseur S; Tomasini R
Cancer Res; 2018 Feb; 78(4):909-921. PubMed ID: 29269518
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer].
Peng F; Zhou J; Sheng W; Zhang D; Dong M
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):90-5. PubMed ID: 24721346
[TBL] [Abstract][Full Text] [Related]
3. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
4. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
Shi Y; Gao W; Lytle NK; Huang P; Yuan X; Dann AM; Ridinger-Saison M; DelGiorno KE; Antal CE; Liang G; Atkins AR; Erikson G; Sun H; Meisenhelder J; Terenziani E; Woo G; Fang L; Santisakultarm TP; Manor U; Xu R; Becerra CR; Borazanci E; Von Hoff DD; Grandgenett PM; Hollingsworth MA; Leblanc M; Umetsu SE; Collisson EA; Scadeng M; Lowy AM; Donahue TR; Reya T; Downes M; Evans RM; Wahl GM; Pawson T; Tian R; Hunter T
Nature; 2019 May; 569(7754):131-135. PubMed ID: 30996350
[TBL] [Abstract][Full Text] [Related]
5. Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.
Göhrig A; Detjen KM; Hilfenhaus G; Körner JL; Welzel M; Arsenic R; Schmuck R; Bahra M; Wu JY; Wiedenmann B; Fischer C
Cancer Res; 2014 Mar; 74(5):1529-40. PubMed ID: 24448236
[TBL] [Abstract][Full Text] [Related]
6. CXCL10 and CCL21 Promote Migration of Pancreatic Cancer Cells Toward Sensory Neurons and Neural Remodeling in Tumors in Mice, Associated With Pain in Patients.
Hirth M; Gandla J; Höper C; Gaida MM; Agarwal N; Simonetti M; Demir A; Xie Y; Weiss C; Michalski CW; Hackert T; Ebert MP; Kuner R
Gastroenterology; 2020 Aug; 159(2):665-681.e13. PubMed ID: 32330476
[TBL] [Abstract][Full Text] [Related]
7. Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.
Secq V; Leca J; Bressy C; Guillaumond F; Skrobuk P; Nigri J; Lac S; Lavaut MN; Bui TT; Thakur AK; Callizot N; Steinschneider R; Berthezene P; Dusetti N; Ouaissi M; Moutardier V; Calvo E; Bousquet C; Garcia S; Bidaut G; Vasseur S; Iovanna JL; Tomasini R
Cell Death Dis; 2015 Jan; 6(1):e1592. PubMed ID: 25590802
[TBL] [Abstract][Full Text] [Related]
8. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
Wang MT; Fer N; Galeas J; Collisson EA; Kim SE; Sharib J; McCormick F
Nat Commun; 2019 Jul; 10(1):3055. PubMed ID: 31296870
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
[TBL] [Abstract][Full Text] [Related]
10. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
12. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
13. Stromal SPOCK1 supports invasive pancreatic cancer growth.
Veenstra VL; Damhofer H; Waasdorp C; Steins A; Kocher HM; Medema JP; van Laarhoven HW; Bijlsma MF
Mol Oncol; 2017 Aug; 11(8):1050-1064. PubMed ID: 28486750
[TBL] [Abstract][Full Text] [Related]
14. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.
Corcoran RB; Contino G; Deshpande V; Tzatsos A; Conrad C; Benes CH; Levy DE; Settleman J; Engelman JA; Bardeesy N
Cancer Res; 2011 Jul; 71(14):5020-9. PubMed ID: 21586612
[TBL] [Abstract][Full Text] [Related]
15. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
[TBL] [Abstract][Full Text] [Related]
16. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow.
Grünwald B; Vandooren J; Gerg M; Ahomaa K; Hunger A; Berchtold S; Akbareian S; Schaten S; Knolle P; Edwards DR; Opdenakker G; Krüger A
Mol Cancer Res; 2016 Nov; 14(11):1147-1158. PubMed ID: 27489361
[TBL] [Abstract][Full Text] [Related]
17. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
18. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
[TBL] [Abstract][Full Text] [Related]
19. Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.
Wrona E; Potemski P; Sclafani F; Borowiec M
Arch Immunol Ther Exp (Warsz); 2021 Feb; 69(1):2. PubMed ID: 33630157
[TBL] [Abstract][Full Text] [Related]
20. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma.
Zhang D; Dai Y; Cai Y; Suo T; Liu H; Wang Y; Cheng Z; Liu H
Tumour Biol; 2016 Feb; 37(2):1699-705. PubMed ID: 26311050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
